© Fundació Glòria Soler, 2026

Legal advice

20.02.2026

The ARI Project at Hospital Clínic-IDIBAPS receives the 2025 National Scientific Patronage Award

  • ARI Project
  • Global Health
  • The ARI Project was launched in 2015 as a charitable initiative linked to the story of Ariana Benedé Jover, honorary patron of the Fundació Glòria Soler, and became a fundraising campaign with a clear goal: to develop a proprietary CAR-T therapy for patients with acute lymphoblastic leukaemia who have no other treatment options.

    Thanks to this impetus, Hospital Clínic-IDIBAPS has developed:

    • ARI-0001, the first CAR-T therapy approved by the Spanish Agency for Medicines and Health Products, indicated for patients with acute lymphoblastic leukaemia and refractory lymphomas. It is the first CAR-T developed entirely in Europe to obtain approval from a regulatory agency.

    • ARI-0002h, aimed at the treatment of relapsed multiple myeloma, approved as a non-industrially manufactured advanced therapy medicinal product.

    In addition, the project has opened up new lines of research with dual CAR-T for lymphomas (ARI-003), CAR-T for HER2+ breast cancer (ARI-HER2) and tumour-infiltrating lymphocyte (TIL) therapies for melanoma and metastatic triple-negative breast cancer.

    Since its implementation, more than 600 patients have been treated with CAR-T at the Clínic Barcelona Comprehensive Cancer Centre, with high remission rates in highly complex diseases.

    Projects related to the news